fda bans glp 1 compounding Zepbound copycats remain online despite FDA ban

The FDA's Decision to Ban Compounds: What You Need to Know

22.87

★★★★☆4.8 (126)

FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified

21.74

★★★★★4.9 (98)

FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified

25.67

★★★★★5.0 (157)

FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified

24.04

★★★★★4.7 (84)

FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified

27.11

★★★★★4.9 (203)

SlimionRX | 🚨 FDA UPDATE — April 1, 2026 (GLP-1 Compounding Just Changed) Most pharmacies haven't realized what the latest FDA clarification actually

22.60

★★★★★5.0 (176)

The FDA is proposing the removal of three GLP-1 drugs from the 503B bulks list of active ingredients that outsourcing facilities can use to make compounded medicines, the agency announced on Thursday

28.60

★★★★★4.8 (132)